← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2011Last known activity
Mar 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (26 distinct, 15 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (33)
- NCT07254936Sponsor investigatorN/AMar 1, 2025
- NCT07254936Lead sponsorN/AMar 1, 2025
- NCT07153601Sponsor investigatorN/AFeb 7, 2025
- NCT07153601Lead sponsorN/AFeb 7, 2025
- NCT07087925Sponsor investigatorN/AJan 15, 2025
- NCT07087925Lead sponsorN/AJan 15, 2025
- NCT07238101Lead sponsorPhase 4May 8, 2024
- NCT07238101Sponsor investigatorPhase 4May 8, 2024
- NCT06298344Sponsor investigatorEarly Phase 1May 1, 2024
- NCT06298344Lead sponsorEarly Phase 1May 1, 2024
- NCT06298344OfficialEarly Phase 1May 1, 2024
- NCT06516861Lead sponsorPhase 1Jan 31, 2024
- NCT06516861OfficialPhase 1Jan 31, 2024
- NCT06516861Sponsor investigatorPhase 1Jan 31, 2024
- NCT06516861CollaboratorPhase 1Jan 31, 2024
Details
- Last known activity
- Mar 1, 2025